The hypothesis is that the implementation of an initial Pharmaceutical Consultation (PC) program based on the provision of standardized information to patients treated for multiple myeloma as a first course of chemotherapy, could optimize their compliance with the delivered per os treatment. The aim of this study is therefore to develop a standardised reference guide of information to be provided during prostate cancer in order to optimise the compliance of patients treated for multiple myeloma as a first course of chemotherapy per os.
Study Type
OBSERVATIONAL
Enrollment
10
evaluating the understanding
Questionnaire. quantitative variables: measurement of the mean and standard deviation or by their median and quartiles according to their distribution.
Time frame: Day 1
evaluating understanding
Questionnaire. qualitative variables: measurement of their number and
Time frame: Day 1
evaluating the quality of information
Questionnaire. quantitative variables: measurement of the mean and standard deviation or by their median and quartiles according to their distribution.
Time frame: Day 1
evaluating quality of information
Questionnaire. qualitative variables: measurement of their number and percentage.
Time frame: Day 1
The time required for the pharmaceutical consultation
minutes
Time frame: Day 1
satisfaction des patients
by an Analogue Visual Scale (0-10-very satisfied)
Time frame: Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.